SAB Biotherapeutics, Inc. - COM NEW (SABS)

Historical Portfolio Holders from Q4 2023 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM NEW
Shares, excl. options Q1 2024: 3.34 M
Holdings value Q1 2024: $15.2 M
Value change Q1 2024: -$15.6 M
Grand Portfolio weight change Q1 2024: 0%
Number of holders: 21
Number of buys Q1 2024: 19
Number of sells Q1 2024: -3
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0%
CUSIP: 78397T202

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	3.34 M	$15.2 M	-$15.6 M			$4.54	21
2023 Q4	8.79 M	$6.06 M	+$6.06 M			$0.69	3